BAKER BROS. ADVISORS LP – Nurix Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$50.58M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+2.84%
quarter
Nurix Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.39M | $13.03 | 3.88M | |
| Q2 2022 | share | Increase | +58.19% | 1.42M shares | 14.80M | $12.67 | 3.88M |
| Q1 2022 | share | 0.00% | 0 shares | -36.66M | $14.01 | 2.45M | |
| Q4 2021 | share | 0.00% | 0 shares | -2.47M | $29.98 | 2.45M | |
| Q3 2021 | share | 0.00% | 0 shares | 8.41M | $29.96 | 2.45M | |
| Q2 2021 | share | 0.00% | 0 shares | -11.19M | $26.53 | 2.45M | |
| Q1 2021 | share | Increase | +37.18% | 665.16K shares | 17.47M | $31.09 | 2.45M |
| Q4 2020 | share | 0.00% | 0 shares | -3.63M | $32.88 | 1.78M | |
| Q3 2020 | share | Increase | 0.00% | 1.78M shares | 62.45M | $34.91 | 1.78M |